Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Cash from Operations (2016 - 2025)

Tvardi Therapeutics' Cash from Operations history spans 13 years, with the latest figure at 5685000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 17.63% to 5685000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 23499000.0, a 28.37% decrease, with the full-year FY2025 number at 23499000.0, down 28.37% from a year prior.
  • Cash from Operations hit 5685000.0 in Q4 2025 for Tvardi Therapeutics, down from 4257000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for TVRD hit a ceiling of 23636000.0 in Q2 2024 and a floor of 34618000.0 in Q1 2023.
  • Historically, Cash from Operations has averaged 13634950.0 across 5 years, with a median of 15743000.0 in 2021.
  • Biggest five-year swings in Cash from Operations: plummeted 1788.35% in 2022 and later skyrocketed 215.61% in 2024.
  • Tracing TVRD's Cash from Operations over 5 years: stood at 1245000.0 in 2021, then plummeted by 1788.35% to 23510000.0 in 2022, then increased by 26.12% to 17370000.0 in 2023, then skyrocketed by 72.18% to 4833000.0 in 2024, then dropped by 17.63% to 5685000.0 in 2025.
  • Business Quant data shows Cash from Operations for TVRD at 5685000.0 in Q4 2025, 4257000.0 in Q3 2025, and 8865000.0 in Q2 2025.